Clinical Trial Update: Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating TAS-102 (trifluridine/tipiracil) in combination with radiation therapy for liver metastases from colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• TAS-102 (Lonsurf) (trifluridine/tipiracil)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED